Endovia Health Sciences closed at $0.18 on Nov 3, up 2.63%, 32.5% below its highest close since Sep 11. Volume of 1.0M shares was 2.06× its 20-day average (well above normal).
Split-adjusted performance: +8.2% over one month.
Short interest was 212.2K shares at the Oct 15 settlement, up 22.0% from the prior report (1.0 days to cover).
No recent articles focused on Endovia Health Sciences.
Quick answers
What does Endovia Health Sciences do?
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets.
What is EDVA's market cap?
$2.05M, based on the Nov 3 close of $0.18.
What sector is EDVA in?
Consumer Staples, in the Food & Tobacco industry.
About Endovia Health Sciences
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology